Pembrolizumab plus chemotherapy following lack of response to nivolumab-based therapy in MSI-High/dMMR advanced gastric cancer: a case report.
Saved in:
| Title: | Pembrolizumab plus chemotherapy following lack of response to nivolumab-based therapy in MSI-High/dMMR advanced gastric cancer: a case report. |
|---|---|
| Authors: | Kawabata R; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan.; Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan., Hara H; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Takeoka T; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Yasuhara Y; Department of Pathology, Sakai City Medical Center, Sakai, Japan., Yoshihara T; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Kitagawa A; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Takeda T; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Tomihara H; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Naito A; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Murakami M; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Noura S; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan., Miyamoto A; Department of Gastrointestinal Surgery, Sakai City Medical Center, 1-1-1, Ebaraji-cho, Nishi-ku, Sakai, Osaka 593-8304 Japan. |
| Source: | International cancer conference journal [Int Cancer Conf J] 2026 Feb 18; Vol. 15 (2), pp. 234-240. Date of Electronic Publication: 2026 Feb 18 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 101734231 Publication Model: eCollection Cited Medium: Internet ISSN: 2192-3183 (Electronic) Linking ISSN: 21923183 NLM ISO Abbreviation: Int Cancer Conf J Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
